10/22/21 – SITC Announces 2021 Medal of Honor Recipients
10/15/21 – SITC Announces Inaugural Class of Fellows to the Academy of Immuno-Oncology
8/10/21 – SITC Forward Fund Announces Recipients of 2021 Postdoctoral Cancer Immunotherapy Fellowships and Awards
8/5/21 – Society for Immunotherapy of Cancer Publishes Clinical Practice Guideline on Immunotherapy for the Treatment of Urothelial Cancer
7/14/21 – Society for Immunotherapy of Cancer Publishes Clinical Practice Guideline on Immune Checkpoint Inhibitor-related Adverse Events
6/14/21 – SITC Steven A. Rosenberg, MD, PhD, Scholars Award: $150,000 in Funding for an Emerging Leader in Immuno-Oncology
5/27/21 – Diversity Panel Discusses Asian Experience in Cancer Research Hosted by Society for Immunotherapy of Cancer and Others
5/20/21 – Oncology News Burst from FDA: Nivolumab
4/23/21 – Oncology News Burst from FDA: Loncastuximab Tesirine-lpyl
4/22/21 – Oncology News Burst from FDA: Dostarlimab-gxly
4/19/21 – Oncology News Burst from FDA: Nivolumab
4/14/21 – Oncology News Burst from FDA: Sacituzumab Govitecan
4/13/21 – SITC to Host Fundamental Two-Day Workshop Focused on Cytokines in Cancer Immunotherapy
4/8/21 – SITC to Host Back-to-Back Workshops on Tumor Cell Surfaceome and Bispecific T cell Engagers
4/7/21 – Oncology News Burst from FDA: Sacituzumab Govitecan
4/1/21 – SITC Announces Two Spatial Technology Awards for Early Career Scientists to Advance Cancer Immunotherapy Research
4/1/21 – Oncology News Burst from FDA: Isatuximab-irfc
3/29/21 – Oncology News Burst from FDA: Idecabtagene Vicleucel
3/23/21 – Oncology News Burst from FDA: Pembrolizumab
3/5/21 – SITC to Host Virtual Leadership Institute Focusing on Professional Development for Women in Cancer Immunotherapy
2/10/21 – SITC Announces $450,000 in Cancer Immunotherapy Fellowships for Early Career Scientists
2/10/21 – Oncology News Burst from FDA: Cemiplimab-rwlc
2/5/21 – Oncology News Burst from FDA: Lisocabtagene Maraleucel
1/25/21 – SITC Announces Mary Dean, JD, CAE, as its Executive Director
1/22/21 – Oncology News Burst from FDA: Nivolumab plus Cabozantinib
1/7/21 – SITC Publishes Clinical Immunotherapy Treatment Guidelines for Lymphoma
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us